Comments: TX HB2529 | 2023-2024 | 88th Legislature

Bill Title: Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2023-05-01 - Left pending in committee [HB2529 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 Texas HB2529 at this time.

Social Comments on TX HB2529

feedback